{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "regularMarketChangePercent": 0.4010695, "regularMarketPrice": 3755.0, "earningsTimestamp": 1681383540, "earningsTimestampStart": 1688536800, "earningsTimestampEnd": 1688968800, "trailingAnnualDividendRate": 84.0, "trailingPE": 23.147577, "trailingAnnualDividendYield": 0.022459893, "epsTrailingTwelveMonths": 162.22, "epsForward": 219.0, "epsCurrentYear": 146.3, "priceEpsCurrentYear": 25.66644, "sharesOutstanding": 78102304, "bookValue": 3297.526, "fiftyDayAverage": 3747.3, "fiftyDayAverageChange": 7.699951, "fiftyDayAverageChangePercent": 0.0020547998, "twoHundredDayAverage": 3683.85, "twoHundredDayAverageChange": 71.1499, "twoHundredDayAverageChangePercent": 0.019314006, "marketCap": 293274157056, "forwardPE": 17.146118, "priceToBook": 1.1387326, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "averageAnalystRating": "3.0 - Hold", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 978307200000, "priceHint": 2, "marketState": "CLOSED", "exchange": "JPX", "shortName": "HISAMITSU PHARMACEUTICAL CO INC", "longName": "Hisamitsu Pharmaceutical Co., Inc.", "messageBoardId": "finmb_877050", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "market": "jp_market", "esgPopulated": false, "regularMarketChange": 15.0, "regularMarketTime": 1683872101, "regularMarketDayHigh": 3765.0, "regularMarketDayRange": "3715.0 - 3765.0", "regularMarketDayLow": 3715.0, "regularMarketVolume": 122700, "regularMarketPreviousClose": 3740.0, "bid": 3745.0, "ask": 3755.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Tokyo", "financialCurrency": "JPY", "regularMarketOpen": 3735.0, "averageDailyVolume3Month": 117100, "averageDailyVolume10Day": 130270, "fiftyTwoWeekLowChange": 525.0, "fiftyTwoWeekLowChangePercent": 0.16253869, "fiftyTwoWeekRange": "3230.0 - 4065.0", "fiftyTwoWeekHighChange": -310.0, "fiftyTwoWeekHighChangePercent": -0.07626076, "fiftyTwoWeekLow": 3230.0, "fiftyTwoWeekHigh": 4065.0, "symbol": "4530.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "408, Tashiro Daikan-machi", "city": "Tosu", "zip": "841-0017", "country": "Japan", "phone": "81 3 5293 1720", "fax": "81 3 5293 1724", "website": "https://www.hisamitsu.co.jp", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Kazuhide  Nakatomi", "age": 50, "title": "Pres, CEO & Director", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Shinichiro  Takao", "title": "MD, Head of BU Div., Management of Corp. Dev., PR, IR & Sustainability Promotion and Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Nobuo  Tsutsumi", "age": 58, "title": "Head of Legal Dept., Mgmt. of Quality Assurance, Pharmacovigilance, Mgmt. of Compliance & Director", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kosuke  Sugiyama", "age": 70, "title": "Sr. MD, Exec. Officer of Management of HR, R&D and Director", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kyu  Saito", "age": 59, "title": "Exec. Officer, Head of International Division & Director", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Shinichi  Murayama", "age": 55, "title": "Exec. Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mitsutoshi  Tsuruta", "title": "Exec. Officer & Head of Ethical Division", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Masaya  Okuno", "title": "Exec. Officer and Head of Sales & Marketing Division, OTC", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Koji  Takiyama", "age": 51, "title": "Sr. Exec. Officer & Director", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 1, "boardRisk": 8, "compensationRisk": 1, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "maxAge": 86400}}], "error": null}}